Bridgewater Associates LP lifted its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 100.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,076 shares of the company's stock after buying an additional 16,077 shares during the period. Bridgewater Associates LP owned approximately 0.06% of Molina Healthcare worth $9,336,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wellington Management Group LLP lifted its position in Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares during the period. FMR LLC grew its stake in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after acquiring an additional 427,276 shares during the period. Geode Capital Management LLC grew its position in Molina Healthcare by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after purchasing an additional 34,992 shares during the period. Invesco Ltd. increased its position in Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after acquiring an additional 294,180 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at about $134,675,000. Institutional investors own 98.50% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the stock. Truist Financial increased their target price on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Barclays dropped their price target on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research note on Friday, February 7th. Stephens reissued an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research note on Thursday, February 6th. Robert W. Baird reaffirmed a "neutral" rating and issued a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday. Finally, UBS Group dropped their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Nine investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $359.42.
Get Our Latest Stock Report on MOH
Molina Healthcare Trading Down 3.0 %
Shares of NYSE MOH traded down $9.81 during trading on Friday, hitting $322.57. 1,443,462 shares of the company were exchanged, compared to its average volume of 660,969. The company has a fifty day moving average price of $314.72 and a 200-day moving average price of $307.93. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $370.99. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a market capitalization of $17.64 billion, a PE ratio of 15.79, a P/E/G ratio of 1.06 and a beta of 0.70.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Insider Transactions at Molina Healthcare
In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.26% of the company's stock.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.